Medovate and JEB Technologies are combining into a single medical-device company under the Medovate name, integrating product development, manufacturing, regulatory and commercial capabilities.

Sernova and Seraxis have entered into a definitive merger agreement to create BetaNova Biotherapeutics, a new clinical-stage company focused on type 1 diabetes islet-cell replacement therapies.